Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Tumor DNA (ctDNA)”

489 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 489 results

Not applicableLooking for participantsNCT06076811
What this trial is testing

DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies

Who this might be right for
Colorectal NeoplasmsColorectal CancerColorectal Adenocarcinoma+3 more
University of Aarhus 1,600
Not applicableActive Not RecruitingNCT04726800
What this trial is testing

Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study

Who this might be right for
Colorectal Cancer
Anna Martling 300
Not applicableStudy completedNCT03435536
What this trial is testing

Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
University Hospital, Toulouse 35
Not applicableLooking for participantsNCT05787197
What this trial is testing

CtDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

Who this might be right for
Metastatic Colorectal CancerCirculating Tumor DNA
GERCOR - Multidisciplinary Oncology Cooperative Group 232
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Not applicableEnrolling By InvitationNCT06145139
What this trial is testing

KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial

Who this might be right for
Renal Cancer
University of Aarhus 500
Not applicableStudy completedNCT06730412
What this trial is testing

CtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 103
Not applicableLooking for participantsNCT04354064
What this trial is testing

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Who this might be right for
Healthy VolunteerProstate CancerHead and Neck Cancer+10 more
Washington University School of Medicine 100
Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Not applicableActive Not RecruitingNCT06089941
What this trial is testing

Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
Centre Henri Becquerel 45
Not applicableUnknownNCT05051592
What this trial is testing

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
National University Hospital, Singapore 40
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Not applicableUnknownNCT05976932
What this trial is testing

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 20
Not applicableUnknownNCT03634826
What this trial is testing

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

Who this might be right for
CarcinomaLung CancerNSCLC+1 more
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07021989
What this trial is testing

CtDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRefractory Hodgkin LymphomaClassic Hodgkin Lymphoma
Michael Spinner, MD 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292207
What this trial is testing

Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer

Who this might be right for
ctDNA MonitoringBreast Cancer
Nagoya City University 30
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Not applicableUnknownNCT02994511
What this trial is testing

Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials

Who this might be right for
Cancer
CCTU- Cancer Theme 100
Testing effectiveness (Phase 2)Looking for participantsNCT04768426
What this trial is testing

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Stanford University 40
Not applicableUnknownNCT01218152
What this trial is testing

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 20
Next Page